CYTOKINETICS, INCORPORATED (CYTK) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

CYTOKINETICS, INCORPORATED Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

CYTOKINETICS, INCORPORATED (CYTK) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of -$82.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-26

• CYTOKINETICS, INCORPORATED effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was -$82.00K.
• CYTOKINETICS, INCORPORATED effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was -$15.82M.
• CYTOKINETICS, INCORPORATED effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was -$3.95M.